CIRM Funded Clinical Trials

Genetic Re-programming of Stem Cells to Fight Cancer


Antoni Ribas
Disease Area: 
Investigator:
CIRM Grant:
Award Value:
$19,999,563
Trial Stage: 
Phase 1
Trial Status: 
Not yet recruiting
Targeted Enrollment:
12
ClinicalTrials.gov ID:
Details: 

There are few options for patients whose cancers have metastasized due to resistance to current therapies. Engineering of patient's own blood-forming stem cells to produce a continual supply of the immune system cell to attack cancer.

Design: 

Single dose. 

Goal: 

Primary: Safety and feasibility. Secondary: Persistence of gene-marked anti-cancer immune cells

Status: 

Enrolling.